1. The Subject Of The Order Is The Successive Deliveries Of A Medicinal Product Used In The Treatment Program For Thrombotic Thrombocytopenic Purpura In The Quantity And Range Specified In The Price Form, Constituting Annex No. 2 To Swz.2. Drug Program Reimbursed By The National Health Fund: B.164 Treatment Of Patients With Thrombotic Thrombocytopenic Purpura (Icd-10: M31.1)
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
